State of Alaska Department of Revenue’s Acceleron Pharma XLRN Stock Holding History

State of Alaska Department of Revenue’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-576	Closed	-$78K	–	1664
2021 Q1	$78K	Buy	576 +97	+20%	+$12.5K	﹤0.01%	1641
2020 Q4	$61K	Sell	479 -22	-4%	-$2.58K	﹤0.01%	1656
2020 Q3	$56K	Buy	+501	New	+$49.9K	﹤0.01%	1620

Other funds holding XLRN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

State of Alaska Department of Revenue's XLRN Position: Q2 2021 in Review

State of Alaska Department of Revenue sold out of Acceleron Pharma (XLRN) in Q2 2021, closing a stake of 576 shares — an estimated $78K sold.

State of Alaska Department of Revenue first reported a position in XLRN in Q3 2020 and held it in 3 quarters. The position peaked at $78K in Q1 2021. 271 funds tracked by Wall St. Rank hold XLRN as of Q2 2021.

State of Alaska Department of Revenue reported no remaining Acceleron Pharma position as of Q2 2021 after selling out during the quarter.
State of Alaska Department of Revenue sold 576 Acceleron Pharma shares in Q2 2021, an estimated $78K.
State of Alaska Department of Revenue first reported a position in Acceleron Pharma in Q3 2020 and held it in 3 quarters.
State of Alaska Department of Revenue's Acceleron Pharma position peaked at $78K in Q1 2021.
271 funds tracked by Wall St. Rank held Acceleron Pharma as of Q2 2021.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2021, filed 12 Jul 2021.